S. Pietranico-Cole

Modulation of receptor and receptor subtype affinities using diastereomeric and enantiomeric monosaccharide scaffolds as a means to structural and biological diversity. A new route to ether synthesis.

A B Smith, M. Cichy-Knight, W. Shakespeare, 1998, Journal of medicinal chemistry.

A Transgenic Platform for Testing Drugs Intended for Reversal of Cardiac Remodeling Identifies a Novel 11βHSD1 Inhibitor Rescuing Hypertrophy Independently of Re-Vascularization

E. Keshet, Oren Gordon, Zhiheng He, 2014, PloS one.

Discovery of camphor-derived pyrazolones as 11β-hydroxysteroid dehydrogenase type 1 inhibitors.

S. So, Yonglin Ren, R. Taub, 2014, Bioorganic & medicinal chemistry letters.

Discovery of 2-[3,5-dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β agonist in clinical trials for the treatment of dyslipidemia.

S. So, I. Klein, Y. Qian, 2014, Journal of medicinal chemistry.

Discovery of pyrazolo[3,4-d]pyrimidine derivatives as GPR119 agonists.

S. So, M. Myers, G. Saha, 2014, Bioorganic & medicinal chemistry letters.

2‐Phenoxy‐nicotinamides are Potent Agonists at the Bile Acid Receptor GPBAR1 (TGR5)

Rainer E. Martin, C. Bissantz, S. Erickson, 2013, ChemMedChem.